Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas
- 18 July 1992
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 340 (8812), 140-142
- https://doi.org/10.1016/0140-6736(92)93214-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Human papillomavirus infection and other risk factors for cervical neoplasia: A case‐control studyInternational Journal of Cancer, 1991
- The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.Proceedings of the National Academy of Sciences, 1991
- Expression of RB and p53 proteins in HPV‐positive and HPV‐negative cervical carcinoma cell linesMolecular Carcinogenesis, 1991
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990
- Increased expression of mutant forms of p53 oncogene in primary lung cancerThe Lancet, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- p53: A Frequent Target for Genetic Abnormalities in Lung CancerScience, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Deficiency of all or part of chromosome 11 in several types of cancer: significance of a reduction in the number of normal chromosomes 11Cytogenetic and Genome Research, 1988
- Suppression of tumorigenicity in somatic cell hybridsCytogenetic and Genome Research, 1986